EMAIL THIS PAGE TO A FRIEND

Nature communications

Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour.


PMID 25739372

Abstract

Anticancer therapies are often compromised by nonspecific effects and challenged by tumour environments' inherent physicochemical and biological characteristics. Often, therapeutic effect can be increased by addressing multiple parameters simultaneously. Here we report on exploiting extravasation due to inherent vascular leakiness for the delivery of a pH-sensitive polymer carrier. Tumours' acidic microenvironment instigates a charge reversal that promotes cellular internalization where endosomes destabilize and gene delivery is achieved. We assess our carrier with an aggressive non-small cell lung carcinoma (NSCLC) in vivo model and achieve >30% transfection efficiency via systemic delivery. Rejuvenation of the p53 apoptotic pathway as well as expression of KillerRed protein for sensitization in photodynamic therapy (PDT) is accomplished. A single administration greatly suppresses tumour growth and extends median animal survival from 28 days in control subjects to 68 days. The carrier has capacity for multiple payloads for greater therapeutic response where inter-individual variability can compromise efficacy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

91238
Diethyl ether, analytical standard
C4H10O
53340
L-Histidine dihydrochloride, ≥99.0% (AT)
C6H9N3O2 · 2HCl